Intravitreal Bevacizumab with or without Triamcinolone for Refractory Diabetic Macular Edema: Long-term Results of a Clinical Trial
Purpose: To report the long-term results of intravitreal bevacizumab (IVB) injection alone or combined, at the time of first IVB injection, with intravitreal triamcinolone acetonide (IVT) for treatment of refractory diabetic macular edema (DME). Methods: In this randomized clinical trial, 115 eyes...
Main Authors: | Nasser Shoeibi, Hamid Ahmadieh, Morteza Entezari, Mehdi Yaseri |
---|---|
Format: | Article |
Language: | English |
Published: |
Knowledge E
2013-01-01
|
Series: | Journal of Ophthalmic & Vision Research |
Subjects: | |
Online Access: | http://www.jovr.org/article.asp?issn=2008-322X;year=2013;volume=8;issue=2;spage=99;epage=106;aulast=Shoeibi |
Similar Items
-
Comparison of intravitreal bevacizumab and triamcinolone acetonide theraphies for diffuse diabetic macular edema
by: Sibel Aksoy, et al.
Published: (2015-06-01) -
Combined intravitreal ranibizumab and posterior subtenon triamcinolone acetonide injections for patients with diabetic macular edema refractory to intravitreal ranibizumab monotherapy
by: Chiung-Yi Chiu, et al.
Published: (2021-01-01) -
Comparison of intravitreal bevacizumab, intravitreal triamcinolone acetonide, and macular grid augmentation in refractory diffuse diabetic macular edema: A prospective, randomized study
by: Rajvardhan Azad, et al.
Published: (2012-01-01) -
Effect of intravitreal injection of triamcinolone acetonide and bevacizumab for macular edema after cataract surgeries
by: Rui-Xue Tang
Published: (2016-01-01) -
Combined intravitreal bevacizumab and posterior sub-Tenon’s triamcinolone acetonide injections for persistent diabetic macular edema
by: Mona M Aly, et al.
Published: (2017-01-01)